COLORECTAL NEOPLASMS
Clinical trials for COLORECTAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL NEOPLASMS trials appear
Sign up with your email to follow new studies for COLORECTAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo for colorectal cancer shows promise but trial ends early
Disease control TerminatedThis study tested a new drug combination (NUFIRI-bev) against a standard treatment (FOLFIRI-bev) for people with advanced colorectal cancer that had already been treated. The goal was to see if the new combo worked better at controlling the cancer. The trial was stopped early, so…
Matched conditions: COLORECTAL NEOPLASMS
Phase: PHASE2 • Sponsor: NuCana plc • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Experimental combo fails to shrink tumors in liver cancer trial
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, in 14 adults with colorectal cancer that had spread to the liver and had not responded to prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, an…
Matched conditions: COLORECTAL NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug, PF-08046052/SGN-EGFRd2, in people with advanced solid tumors like colorectal, lung, head and neck, and pancreatic cancers that could not be removed or had spread. The goal was to find a safe dose and check for side effects. The study was terminated e…
Matched conditions: COLORECTAL NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Radiation therapy study seeks immune clues for better cancer treatment
Knowledge-focused TerminatedThis study looked at how the immune system responds during high-dose radiation therapy in people with liver, colorectal, melanoma, or kidney cancers. Researchers collected blood samples before, during, and after treatment to track immune cells and other markers. The goal was to l…
Matched conditions: COLORECTAL NEOPLASMS
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC